f.pires
TL2 · Essen
Contributes reviews on supplier material. Based in Essen.
Joined 3 August 2025 · last posted 2d
109 posts, newest first. Showing up to 150.
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #141 · Practice › Reconstitution · 26 Jul 2026 · 1 like Post #140 is the version of this I will quote in future. One addition. Choosing a concentration on purpose rather than by accident: starting with "I want to draw 0.5 mL…
-
Why the Start Here categories exist, and what they are not for Replied, post #38 · Start Here › Welcome · 25 Jul 2026 · 0 likes Muting is under-used here. A category you mute stops appearing in Latest for you, and you can unmute it in a second. Most long-term members read four or five categories…
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #79 · Practice › Interactions · 23 Jul 2026 · 0 likes The most defensible general position in this subcategory: identify the plausible mechanism, check whether it has been studied, and where it has not, say that rather…
-
Retatrutide mass and identity: what a report should show Replied, post #23 · Compounds › Retatrutide · 21 Jul 2026 · 12 likes Post #22 is the version of this I will quote in future. One addition. Retatrutide mass and identity is well covered in the tag pages, and the older discussions are…
-
eGFR fluctuation and the creatinine denominator problem — the long version Replied, post #22 · Clinical › Bloodwork · 21 Jul 2026 · 0 likes Glycaemic markers integrate over different periods. A point glucose and a longer-term marker disagreeing is not a contradiction; it is two different questions.
-
Tracking intake honestly when appetite is absent Replied, post #103 · Nutrition & Training › Protein & intake · 18 Jul 2026 · 1 like An update on my earlier tracking intake post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
-
Pooling trials with different estimands Replied, post #106 · Evidence › Meta-analyses · 17 Jul 2026 · 0 likes Pooling trials with different estimands came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the…
-
Which categories are strict and which are relaxed, honestly Replied, post #18 · Start Here › Welcome · 15 Jul 2026 · 0 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Follow-up: Sleep quality changes during weight loss Replied, post #61 · Wellbeing › Sleep · 4 Jul 2026 · 13 likes On Sleep quality changes during weight I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #51 · Start Here › Welcome · 30 Jun 2026 · 24 likes That reframing is the whole thing. The facts I already had.
-
Electrolyte supplements: which ones do anything Replied, post #42 · Nutrition & Training › Hydration & electrolytes · 28 Jun 2026 · 0 likes Answering the question post #40 raises rather than the one it answers. Reduced intake reduces electrolyte intake alongside everything else, which is the mechanism…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #51 · Analytics › HPLC & UHPLC · 20 Jun 2026 · 2 likes Whatever the answer on Carryover turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, invite the correction.
-
What I would want from a home test that does not exist yet — what changed since Replied, post #60 · Analytics › Home & field testing · 19 Jun 2026 · 0 likes Picking up post #59: that is the part I would want checked first. Ultraviolet absorbance at 280 nanometres estimates concentration for peptides containing aromatic…
-
[2026 update] Waist circumference technique and its repeatability Replied, post #17 · Outcomes › Progress reports · 16 Jun 2026 · 1 like Self-reported intake is optimistic in a consistent direction, and saying so in your own report is more credible than not. That is the version I would defend. It is not…
-
Insurance and replacement policies, compared Replied, post #17 · Sourcing › Logistics · 13 Jun 2026 · 0 likes Where I part company with post #16, and it is a narrow parting. Insurance and replacement policies sits at the boundary between what this community can usefully discuss…
-
Journal club: what we got wrong in an earlier session Replied, post #2 · Evidence › Journal club · 12 Jun 2026 · 17 likes Sessions on negative or null results are consistently the most instructive and the hardest to get anyone to attend.
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #76 · Practice › Administration · 10 Jun 2026 · 4 likes Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue from repeated injection in one area — changes local tissue absorption. Avoid…
-
What a good consultation looks like from the other side Replied, post #47 · Clinical › Prescriber conversations · 6 Jun 2026 · 0 likes The version of good consultation that circulates here is a simplification of a simplification. It is not wrong, but it has lost the conditions under which it holds, and…
-
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #32 · Practice › Storage & stability · 31 May 2026 · 12 likes Adsorption to container surfaces removes peptide from solution without changing how the solution looks. In dilute preparations that loss can be a meaningful proportion,…
-
[2026 update] What a good consultation looks like from the other side Replied, post #34 · Clinical › Prescriber conversations · 29 May 2026 · 0 likes Helpful, and short, which on this subject is harder than long.
-
An appeal that succeeded, with the letter structure — the long version Replied, post #19 · Access › Insurance & coverage · 27 May 2026 · 0 likes This follows post #16 rather than contradicting it. The most useful thing anyone has posted about appeal in this category was a table of what had been measured and by…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Started this topic · Evidence › Journal club · 24 May 2026 · 5 likes Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field — setting out what I have, and where I think it stops being reliable. Collecting what is…
-
Why we ask for units every single time, with three examples of what goes wrong — what… Replied, post #16 · Start Here › How to Ask · 24 May 2026 · 13 likes Five questions in one post gets you one answer: the easiest one, usually not the one you needed most. Post them separately or pick the one that depends on the others…
-
Naming conventions for research peptides and the confusion they cause Replied, post #3 · Compounds › Other compounds · 13 May 2026 · 0 likes Research use only, not approved for human use, and in this subcategory the compounds vary enormously in how much is known about them. It is worth establishing which end…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #51 · Compounds › Repair & healing peptides · 10 May 2026 · 11 likes The strongest argument against my own position on Stability of BPC-157, stated as well as I can state it, since nobody else has yet.
-
Chain of custody for a sample you posted yourself — one year on Replied, post #17 · Sourcing › Independent verification · 7 May 2026 · 3 likes The honest answer on Chain of custody is that it depends, and the useful part is the list of what it depends on. Four items, in rough order of how much they matter.…
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #23 · Safety › Contraindications · 29 Apr 2026 · 1 like Taking post #22 at face value and following it one step further. Somebody's condition being on a list does not settle the decision, and somebody's condition being…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #57 · Data & Tools › Datasets · 27 Apr 2026 · 26 likes Where the community side-effect dataset discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are the…
-
The anatomy of a question that gets answered within an hour Replied, post #29 · Start Here › How to Ask · 27 Apr 2026 · 32 likes On post #27 — agreed on the reasoning, with one qualification. Nobody minds being asked to explain a term. The people who use them most are the quickest to define them,…
-
Sample handling between despatch and injection Replied, post #35 · Analytics › Method validation · 12 Apr 2026 · 18 likes That is the distinction I keep failing to hold on to. Written down now.
-
Reconstituting a multi-strength kit without mixing yourself up — what changed since Replied, post #4 · Practice › Reconstitution · 12 Apr 2026 · 2 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does.
-
Follow-up: State-level differences that actually matter Replied, post #61 · Regional › North America · 7 Apr 2026 · 25 likes This is the answer, and the reason it is the answer is the more useful part.
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #99 · Clinical › Special populations · 5 Apr 2026 · 16 likes Dedicated trials in under-studied populations are the only real remedy and several are ongoing, which is worth saying rather than speculating.
-
Air bubbles in a subcutaneous injection: the honest risk assessment — does this still… Replied, post #19 · Practice › Administration · 17 Mar 2026 · 31 likes Alcohol swabbing and letting the site dry is the whole of the preparation for a subcutaneous injection into intact skin. Injecting before it dries is what stings. That…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #44 · Research Methods › N-of-1 designs · 8 Mar 2026 · 1 like Washout periods: after stopping a medication, how long does it take for the effect to wash out? For compounds with a week-long half-life, roughly a month is needed to…
-
The lowest dose that does anything: is that a real question? Replied, post #3 · Practice › Dosing & titration · 28 Feb 2026 · 1 like The maximum studied dose is a fact about the trial and not a ceiling on the molecule. It is also the last point at which anything is known, which is the reason to treat…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #94 · Pharmacology › Pharmacokinetics · 28 Feb 2026 · 8 likes Steady state is approached in roughly four to five half-lives. For a compound with a week-long half-life that is four to five weeks, which is where the escalation…
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #83 · Meta › Site feedback · 26 Feb 2026 · 14 likes Last piece of feedback: the site is much better on a narrow screen than it was six months ago and nobody said so at the time. Recording it because only the failures…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #45 · Pharmacology › Pharmacokinetics · 17 Feb 2026 · 17 likes A methods point on Washout rather than a substantive one: if the comparison is not like for like, the difference you are measuring is the difference in method.
-
Realistic expectations for strength while losing weight quickly Replied, post #63 · Nutrition & Training › Resistance training · 16 Feb 2026 · 0 likes Maintenance is the goal: preserving lean mass and strength during weight loss is the goal of resistance training in this context, not building new muscle. That goal is…
-
Trifluoroacetate content and its consequences Replied, post #122 · Analytics › Impurities & related substances · 10 Feb 2026 · 23 likes An observation about trifluoroacetate content that I cannot explain and am posting anyway, on the principle that unexplained observations are more useful public than…
-
Request declined, with reasoning — what changed since Replied, post #11 · Meta › Feature requests · 7 Feb 2026 · 10 likes Tracking: staff will update the status of feature requests (under consideration, planned, implemented, declined). Checking back lets you know the fate of your suggestion.
-
Preprint servers and what screening they do Replied, post #43 · Evidence › Preprints · 2 Feb 2026 · 3 likes Where I part company with post #41, and it is a narrow parting. Always label it as a preprint in any discussion. A preprint is not a published trial and it is not…
-
Completing a dose with a second syringe, and the dead-volume arithmetic Started this topic · Practice › Administration · 25 Jan 2026 · 33 likes Posting this under the heading it deserves: Completing a dose with a second syringe, and the dead-volume arithmetic Everything below is what sits behind that. I have…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #49 · Clinical › Special populations · 23 Jan 2026 · 0 likes Noted, and I have changed what I was going to do on the strength of it.
-
Early satiety becoming a problem rather than a benefit Replied, post #25 · Practice › Side effects · 14 Jan 2026 · 26 likes Hair shedding some months in is described frequently here and is more consistent with rapid weight loss than with any direct drug effect. That distinction matters…
-
Distinguishing expected GI effects from something that needs urgent attention Replied, post #80 · Practice › Side effects · 12 Jan 2026 · 19 likes The published rates come from populations that were titrated on a defined schedule with clinical supervision. Rates from a forum are not comparable and are biased by…
-
Heterogeneity as information rather than as a nuisance Replied, post #57 · Evidence › Meta-analyses · 11 Jan 2026 · 6 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #43 · Pharmacology › Receptor biology · 5 Jan 2026 · 20 likes Post #40 is right about the mechanism and I think understates the practical bit. The claim about Receptor desensitisation upthread is stronger than its source supports.…
-
How to read a phase 2 result without treating it as a phase 3 result — what changed since Replied, post #28 · Compounds › Retatrutide · 3 Jan 2026 · 0 likes Heart rate increased in a dose-dependent way in the phase 2 work. That is not a footnote — it is one of the specific things phase 3 exists to characterise, and it is…
-
[2026 update] Are there stupid questions here? A staff answer, at length Replied, post #12 · Start Here › Welcome · 14 Dec 2025 · 5 likes The moderation log is public. Every staff action is logged with the rule cited and the reasoning stated. If you get moderated, the explanation is there and it is worth…
-
The decimal-point error, and the habit that catches it Replied, post #19 · Practice › Reconstitution · 14 Dec 2025 · 23 likes Post #17 answers the question as asked. The question underneath it is different. The honest answer on decimal-point error is that it depends, and the useful part is the…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #107 · Practice › Reconstitution · 26 Nov 2025 · 13 likes What would change my mind on decimal-point error is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather…
-
Revisiting: Aggregates and why a purity assay may miss them entirely Replied, post #52 · Analytics › Impurities & related substances · 24 Nov 2025 · 8 likes Freeze-drying itself does not generate impurities in any significant way. Handling before and after it does, which is why transit conditions belong in the discussion.…
-
Documentation that appears only after payment Replied, post #82 · Sourcing › Red flags · 20 Nov 2025 · 0 likes Something worth flagging about documentation: the strongest-sounding claims in this thread are the ones with no source attached, which is the usual pattern and not a…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #33 · Compounds › Semaglutide · 11 Nov 2025 · 22 likes On the injection-day question: the labelling for licensed semaglutide allows the day to be changed provided at least two days separate the two injections. That interval…
-
Publishing an inconvenient result: a case study — the long version Replied, post #24 · Sourcing › Independent verification · 31 Oct 2025 · 27 likes This follows post #22 rather than contradicting it. Combining a chromatographic result with a documentation review gives a more complete picture than two…
-
Reading SURMOUNT-1 without the press release — one year on Replied, post #18 · Compounds › Tirzepatide · 30 Oct 2025 · 1 like Post #14 and I disagree about the size of the effect, not about the direction. Comparisons between the tirzepatide and semaglutide programmes across trials rather than…
-
Long-time reader, first-time poster Started this topic · Lounge › Introductions · 30 Oct 2025 · 32 likes On the subject in the title: Long-time reader, first-time poster Working notes rather than a conclusion. Trying to work out what would count as evidence on long-time…
-
Personal import allowances, compared — a second dataset Replied, post #13 · Access › International · 24 Oct 2025 · 0 likes On Personal import allowances I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating them…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #85 · Practice › Storage & stability · 15 Oct 2025 · 0 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed. The literature is thinner on this than…
-
Detection wavelength and why 214 nm and 280 nm disagree Replied, post #60 · Analytics › HPLC & UHPLC · 7 Oct 2025 · 7 likes Post #58 answers the question as asked. The question underneath it is different. Before anything else: what was the gradient, and at what wavelength? Area percent at…
-
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #39 · Compounds › Tirzepatide · 12 Sep 2025 · 0 likes Comparisons between the tirzepatide and semaglutide programmes across trials rather than within one are weak. Different populations, different durations, different…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #52 · Practice › Side effects · 10 Sep 2025 · 0 likes I disagree with the framing of nausea timeline above, and I think it is a substantive disagreement rather than a terminological one. Setting out why, so it can be…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #17 · Data & Tools › Datasets · 4 Sep 2025 · 21 likes Date every record. A dataset assembled over two years without dates cannot distinguish a change over time from a change in who was contributing. The strength of my…
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #68 · Clinical › Special populations · 26 Aug 2025 · 2 likes On post #64 — agreed on the reasoning, with one qualification. Pancreatitis history: the compounds can rarely trigger pancreatitis. A history of pancreatitis makes…
-
About the Prescriber conversations category Replied, post #3 · Clinical › Prescriber conversations · 21 Aug 2025 · 0 likes As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
-
Thyroid function tests during substantial weight change Replied, post #28 · Clinical › Bloodwork · 12 Aug 2025 · 7 likes Small methodological point on thyroid function tests during substantial: repeating a measurement is cheap and resolves most of what is being argued about here at no…
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #106 · Wellbeing › Mental health · 8 Aug 2025 · 24 likes Substance use: if someone has a history of substance use, appetite suppression and weight loss can shift thinking about body and substance use. This is a risk factor…
-
Travel coolers and how long they really hold Replied, post #10 · Devices › Cold chain · 31 Jul 2025 · 20 likes Two claims get bundled together under travel coolers and they need separating. The descriptive one — this is what was observed — is usually well supported. The causal…
-
Canadian access and provincial variation — one year on Replied, post #38 · Regional › North America · 27 Jul 2025 · 2 likes Coming back to post #34, because the follow-up matters more than the original answer. Adding a small correction to the Canadian access and provincial variation summary…
-
Follow-up: Why appetite effects are mostly central Replied, post #6 · Pharmacology › Receptor biology · 26 Jul 2025 · 29 likes Appetite effects looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in our favour.
-
Interim analyses and stopping rules — does this still hold? Replied, post #9 · Evidence › Trials · 26 Jun 2025 · 8 likes Distinguishing three things in the Interim analyses and stopping rules discussion that keep getting used interchangeably: the observation, the proposed mechanism, and…
-
[2026 update] Clearance pathways and what renal impairment changes Replied, post #56 · Pharmacology › Pharmacokinetics · 20 Jun 2025 · 2 likes Distinguishing three things in the Clearance pathways discussion that keep getting used interchangeably: the observation, the proposed mechanism, and the recommendation…
-
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #57 · Evidence › Journal club · 15 Jun 2025 · 0 likes No disagreement from me. Posting only so the question does not look ignored.
-
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #46 · Evidence › Trials · 6 Jun 2025 · 11 likes Composite endpoints should be read component by component. A composite driven entirely by its softest component is a different finding from one where the components…
-
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #59 · Compounds › Other compounds · 28 May 2025 · 5 likes Post #57 answers the question as asked. The question underneath it is different. Anyone submitting an unusual compound for testing should tell the laboratory what it is…
-
Sequence verification for an obscure compound: how it is done Replied, post #46 · Compounds › Other compounds · 27 May 2025 · 10 likes An honest declaration on sequence verification: I have a prior here and it is strong enough that you should weight what I say downward. Stating it rather than hiding it.
-
Which panel is worth repeating and which is worth ignoring Replied, post #25 · Clinical › Bloodwork · 25 May 2025 · 13 likes I had written a reply contradicting post #23 and deleted it. Here is what survived. Trying to state the panel position in a way that someone who disagrees would…
-
Coming back to: Checking someone else's arithmetic: a worked example thread Replied, post #4 · Practice › Reconstitution · 18 May 2025 · 21 likes Post #2 describes the usual case. This is about the unusual one. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a…
-
Shakes versus food: a pragmatic assessment — the long version Replied, post #28 · Nutrition & Training › Protein & intake · 18 May 2025 · 0 likes Shakes versus food looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in our favour.
-
Regression to the mean in progress reports Replied, post #10 · Research Methods › Statistics · 16 May 2025 · 3 likes Post #8 and I disagree about the size of the effect, not about the direction. Baseline imbalance in a randomised trial is expected by chance and adjusting for it post…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #7 · Compounds › Repair & healing peptides · 4 May 2025 · 6 likes Route arguments — local versus systemic — are made confidently in this subcategory on very little published basis. The honest position is that the comparison has not…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #30 · Practice › Storage & stability · 28 Apr 2025 · 11 likes Offering a way to settle published stability data actually covers rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the…
-
Reading an MS report that only gives you a single number Replied, post #49 · Analytics › Mass spectrometry · 10 Apr 2025 · 0 likes Building on post #46 rather than restating it. Positional isomers and epimers are mass-identical. Any argument that a mass result rules them out is wrong, and it is the…
-
When to suspect the method rather than the sample Replied, post #109 · Analytics › Method validation · 5 Apr 2025 · 19 likes Worth separating two things that post #106 runs together. Precision and repeatability: within-run and between-run variability of the method. Acceptance criterion is…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #71 · Practice › Reconstitution · 4 Apr 2025 · 0 likes Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are reconstituting all of them, writing the concentration on each vial in…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #66 · Documentation › Doc review · 20 Mar 2025 · 8 likes Where content is lifted from a topic, attribution should be in the document rather than only in the review thread.
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #84 · Sourcing › Vendor reports · 17 Mar 2025 · 17 likes Confirming post #81 from a second method, which matters more than confirming it from a second person. Photograph the vial and the label before opening. It costs ten…
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #115 · Compounds › Other compounds · 15 Mar 2025 · 0 likes This is the answer, and the reason it is the answer is the more useful part.
-
When "no data" is the complete and final answer Replied, post #113 · Compounds › Other compounds · 9 Mar 2025 · 17 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #36 · Sourcing › Regulatory · 1 Mar 2025 · 6 likes Pharmaceutical compounding rules would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.
-
Validating a method you did not develop — does this still hold? Replied, post #36 · Analytics › Method validation · 23 Feb 2025 · 0 likes Post #34 put the caveat in the right place and I want to underline it. Stability-indicating method: one that can separate a compound from its degradation products.…
-
Distinguishing a deletion sequence by mass alone Replied, post #106 · Analytics › Mass spectrometry · 19 Feb 2025 · 2 likes I had written a reply contradicting post #102 and deleted it. Here is what survived. The honest summary of what a mass result buys you: it narrows the field of what the…
-
What we do not know about retatrutide, listed explicitly Replied, post #96 · Compounds › Retatrutide · 14 Feb 2025 · 14 likes Worth separating two things that post #94 runs together. Heart rate increased in a dose-dependent way in the phase 2 work. That is not a footnote — it is one of the…
-
Follow-up: What other technical communities get right that we do not Replied, post #12 · Lounge › Off topic · 6 Feb 2025 · 24 likes Lounge question, no agenda: does anyone else keep a physical notebook for this rather than a file? Mine is more use than anything I have typed, and I cannot entirely…
-
Coming back to: Recording a dissent on a document rather than suppressing it Replied, post #30 · Documentation › Doc review · 29 Jan 2025 · 0 likes Everything in post #28 holds. The case it does not cover is the one I have. A review date is a commitment rather than a formality, and a shorter cycle for a fast-moving…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #14 · Access › International · 26 Jan 2025 · 0 likes Picking up post #13: that is the part I would want checked first. The most useful reply I ever got about Cross-border purchase within was a request to state my units.…
-
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #34 · Analytics › COA interpretation · 21 Jan 2025 · 8 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
-
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #4 · Analytics › COA interpretation · 14 Jan 2025 · 17 likes Certificates from a supplier's own laboratory are not independent by definition. That is not an accusation, it is a description, and it is why independent submission…
-
[2026 update] New subcategory: rationale and scope Replied, post #89 · Meta › Announcements · 24 Dec 2024 · 31 likes I read post #85 twice before replying, because I had assumed the opposite. What I would check first on New subcategory is whether the thing being measured moved or…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #62 · Compounds › Semaglutide · 22 Dec 2024 · 0 likes I read post #60 twice before replying, because I had assumed the opposite. Molecular mass of semaglutide is one of those subjects where the general answer and the…
-
Why "any advice?" is the least effective ending for a post Replied, post #123 · Start Here › How to Ask · 9 Dec 2024 · 28 likes Post #120 is the version of this I will quote in future. One addition. "Has anyone had this happen" gets you anecdotes. "What would cause this, and what would…
-
Washout with a one-week half-life: the arithmetic Replied, post #54 · Research Methods › N-of-1 designs · 2 Dec 2024 · 16 likes The strongest argument against my own position on washout, stated as well as I can state it, since nobody else has yet.
-
Time to steady state after a dose increase Replied, post #23 · Pharmacology › Pharmacokinetics · 2 Nov 2024 · 0 likes Understood, and I withdraw the assumption I opened with.
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #64 · Sourcing › Independent verification · 17 Sep 2024 · 0 likes That is a cleaner way of putting what I was circling around.
-
Follow-up: Dead volume across syringe and needle combinations Replied, post #19 · Devices › Syringes & needles · 9 Aug 2024 · 2 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
-
The mass-error checker and its intended scope Replied, post #122 · Data & Tools › Calculators · 14 Jul 2024 · 9 likes Worth stating the null on mass-error checker before we explain it: the observation may be nothing. That possibility deserves a sentence and usually does not get one.
-
Tracking a preprint to publication: a worked example — the long version Replied, post #12 · Evidence › Preprints · 1 Jul 2024 · 13 likes Post #9 answers the question as asked. The question underneath it is different. Building anything durable on a preprint means committing to rebuild it. That is a…